The 238 new COVID-19 cases were reported from 17 states.

Nigeria on Monday recorded 238 new COVID-19 infections in 17 states as concerns about the Oxford/AstraZeneca vaccines the country received almost four million doses of deepens.

The new daily figure is higher than the 120 cases reported a day earlier as the lowest figure this year.

Monday’s figure raised the total number of infections in the country to 160,895.

This is according to an update published by the Nigeria Centre for Disease Control (NCDC) Monday night.

After reporting an average of 1, 000 infections daily between December 2020 and January, infection figures have relatively dropped with daily cases hovering between 120 and 709 in the past three weeks.

The death toll from the disease has reduced a bit. No death was recorded on Sunday.

According to the NCDC data, three fatalities were recorded on Monday raising the fatality tally to 2,016 in total.


The 238 new cases were reported from 17 states – Lagos (72), Kwara (28), Bauchi (19), Kaduna (19), Edo (17), Ogun (15), Nasarawa (13), Rivers (10), FCT (9), Ondo (8), Akwa Ibom (5), Gombe (5), Niger (5), Osun (5), Plateau (4), Oyo (3), and Kano (1).

Lagos had the highest figure on Monday with 72 new cases followed by Kwara and Bauchi with 28 and 19 infections respectively.

Since the pandemic broke out in Nigeria in February last year, the country has carried out over 1.6 million tests.

More than two-thirds of the over 160,000 people infected by COVID-19 in Nigeria have recovered after treatment.

According to NCDC data published Sunday night, a total of 145,752 have recovered after treatment.

Meanwhile, over 18,000 infections are still active in the country.


Nigerian authorities on Monday said at least 8,000 Nigerians have received their first dose of the Oxford-AstraZeneca COVID-19 vaccines thus far.

The Executive Director of the National Primary Health Care Development Agency (NPHCDA), Faisal Shuaib, while speaking at the weekly briefing of the Presidential Task Force (PTF) on COVID-19, on Monday, said no serious adverse effects have been reported from those who have been vaccinated.